Roche Holding AG

Roche Holding AG logo
πŸ‡¨πŸ‡­Switzerland
Ownership
Public
Established
1896-01-15
Employees
103.6K
Market Cap
$270.5B
Website
http://www.roche.com

A Phase IIIB Open-Label, Comparative Study to Evaluate Saquinavir Soft Gel Capsule (SGC) Treatment in Combination With Other Antiretrovirals in HIV-1 Infected Antiretroviral-Naive Patients

Phase 3
Completed
Conditions
First Posted Date
2001-08-31
Last Posted Date
2005-06-24
Lead Sponsor
Hoffmann-La Roche
Target Recruit Count
375
Registration Number
NCT00002178
Locations
πŸ‡ΊπŸ‡Έ

Dr Charles Farthing, Los Angeles, California, United States

πŸ‡ΊπŸ‡Έ

Community Research Initiative, Brookline, Massachusetts, United States

A Study of Saquinavir Soft Gel Capsules (SGC) Used in Combination With Two Other Anti-HIV Drugs in Patients With HIV-Associated Kidney Disease

First Posted Date
2001-08-31
Last Posted Date
2005-06-24
Lead Sponsor
Hoffmann-La Roche
Target Recruit Count
24
Registration Number
NCT00002397
Locations
πŸ‡ΊπŸ‡Έ

Mount Sinai Med Ctr, New York, New York, United States

A Comparison of Saquinavir Hard- and Soft-Gelatin Capsules in HIV-Infected Patients

Phase 1
Completed
Conditions
First Posted Date
2001-08-31
Last Posted Date
2005-06-24
Lead Sponsor
Hoffmann-La Roche
Target Recruit Count
80
Registration Number
NCT00002383
Locations
πŸ‡ΊπŸ‡Έ

Harkness Pavilion, New York, New York, United States

πŸ‡ΊπŸ‡Έ

Mt Zion Hosp of UCSF / HIV Research Ctr, San Francisco, California, United States

πŸ‡ΊπŸ‡Έ

Davis Med Ctr, San Francisco, California, United States

and more 7 locations

A Study to Compare Two Anti-HIV Drug Combinations

Phase 3
Completed
Conditions
First Posted Date
2001-08-31
Last Posted Date
2005-06-24
Lead Sponsor
Hoffmann-La Roche
Target Recruit Count
146
Registration Number
NCT00002447
Locations
πŸ‡ΊπŸ‡Έ

UCSF - San Francisco Gen Hosp, San Francisco, California, United States

πŸ‡ΊπŸ‡Έ

Saint Michael's Med Ctr / Dept of Infectious Diseases, Newark, New Jersey, United States

πŸ‡ΊπŸ‡Έ

Associates in Research, Fort Myers, Florida, United States

and more 23 locations

T-20 With Anti-HIV Combination Therapy for Patients With Prior Anti-HIV Drug Treatment and/or Drug Resistance to Each of the Three Classes of Approved Anti-HIV Drugs

Phase 3
Completed
Conditions
First Posted Date
2001-08-31
Last Posted Date
2005-06-24
Lead Sponsor
Hoffmann-La Roche
Target Recruit Count
525
Registration Number
NCT00008528
Locations
πŸ‡ΊπŸ‡Έ

Massachusetts Gen Hosp, Boston, Massachusetts, United States

πŸ‡ΊπŸ‡Έ

Nicholas Bellos, Dallas, Texas, United States

πŸ‡ΊπŸ‡Έ

Univ of Texas Med Branch, Galveston, Texas, United States

and more 34 locations

A Study of Saquinavir and Zalcitabine, Used Alone and Together, in the Treatment of Advanced HIV Infection in Patients Who Stopped Taking or Who Cannot Take Zidovudine

Phase 2
Completed
Conditions
First Posted Date
2001-08-31
Last Posted Date
2005-06-24
Lead Sponsor
Hoffmann-La Roche
Target Recruit Count
900
Registration Number
NCT00002333
Locations
πŸ‡ΊπŸ‡Έ

Univ of Miami Dept of Medicine, Miami, Florida, United States

πŸ‡ΊπŸ‡Έ

Sunnyvale Med Clinic, Sunnyvale, California, United States

πŸ‡ΊπŸ‡Έ

Rush Presbyterian - Saint Luke's Med Ctr, Chicago, Illinois, United States

and more 44 locations

T-20 in HIV Patients With Prior Drug Treatment and/or Resistance to Each of the Three Classes of Anti-HIV Drugs

Phase 3
Completed
Conditions
First Posted Date
2001-08-31
Last Posted Date
2005-06-24
Lead Sponsor
Hoffmann-La Roche
Target Recruit Count
525
Registration Number
NCT00021554
Locations
πŸ‡³πŸ‡±

Natac Med Centre, Amsterdam, Netherlands

πŸ‡³πŸ‡±

Univ Medical Center Utrecht, CX Utrecht, Netherlands

πŸ‡¨πŸ‡­

Univ Hosp Basel / Med Outpatient Dept, Basel, Switzerland

and more 34 locations

A Comparison of Three Anti-HIV Drug Combinations Containing Saquinavir Soft Gelatin Capsules Used in HIV-1 Infected Patients

Phase 3
Completed
Conditions
First Posted Date
2001-08-31
Last Posted Date
2005-06-24
Lead Sponsor
Hoffmann-La Roche
Target Recruit Count
825
Registration Number
NCT00002378
Locations
πŸ‡ΊπŸ‡Έ

Northwestern Univ Med Ctr, Chicago, Illinois, United States

πŸ‡ΊπŸ‡Έ

Lehigh Valley Hosp, Allentown, Pennsylvania, United States

πŸ‡ΊπŸ‡Έ

North Texas Infectious Disease Consultants, Dallas, Texas, United States

and more 98 locations

A Study to Compare Three Doses of T-20 When Given in Combination With Abacavir, Amprenavir, Ritonavir, and Efavirenz to HIV-Infected Adults

Phase 2
Completed
Conditions
First Posted Date
2001-08-31
Last Posted Date
2005-11-15
Lead Sponsor
Hoffmann-La Roche
Target Recruit Count
68
Registration Number
NCT00002239
Locations
πŸ‡ΊπŸ‡Έ

UCLA Care Ctr, Los Angeles, California, United States

πŸ‡ΊπŸ‡Έ

AIDS Research Consortium of Atlanta, Atlanta, Georgia, United States

πŸ‡ΊπŸ‡Έ

Pennsylvania Oncology and Hematology Associates, Philadelphia, Pennsylvania, United States

and more 16 locations

Safety and Effectiveness of Adding Saquinavir (FORTOVASE) in Soft Gel Capsule Form to an Anti-HIV Drug Combination in HIV-Infected Patients

Phase 4
Completed
Conditions
First Posted Date
2001-08-31
Last Posted Date
2005-06-24
Lead Sponsor
Hoffmann-La Roche
Target Recruit Count
80
Registration Number
NCT00002229
Locations
πŸ‡ΊπŸ‡Έ

Univ of Illinois Hosp at Chicago, Chicago, Illinois, United States

πŸ‡΅πŸ‡·

Programe DeSIDA De San Juan, San Turce, Puerto Rico

πŸ‡ΊπŸ‡Έ

Univ of Virginia Health Sciences Ctr, Charlottesville, Virginia, United States

and more 19 locations
Β© Copyright 2024. All Rights Reserved by MedPath